ici d8731 has been researched along with angiotensin ii in 4 studies
| Studies (ici d8731) | Trials (ici d8731) | Recent Studies (post-2010) (ici d8731) | Studies (angiotensin ii) | Trials (angiotensin ii) | Recent Studies (post-2010) (angiotensin ii) |
|---|---|---|---|---|---|
| 15 | 0 | 0 | 38,152 | 1,089 | 7,413 |
| Protein | Taxonomy | ici d8731 (IC50) | angiotensin ii (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.002 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0055 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.004 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bassenge, E; Busse, R; Hecker, M; Pörsti, I | 1 |
| Auch-Schwelk, W; Duske, E; Fleck, E; Hess, B; Hildebrandt, AG; Klein, U; Regitz-Zagrosek, V; Steffen, C | 1 |
| Auch-Schwelk, W; Betz, M; Duske, E; Fleck, E; Hink, U; Unkelbach, M | 1 |
| Cameron, NE; Cotter, MA; Dines, KC; Maxfield, EK | 1 |
4 other study(ies) available for ici d8731 and angiotensin ii
| Article | Year |
|---|---|
Dual action of angiotensin II on coronary resistance in the isolated perfused rabbit heart.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine; Amino Acid Oxidoreductases; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Coronary Circulation; Coronary Vessels; Cyclooxygenase Inhibitors; Endothelium, Vascular; Heart; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Myocardial Contraction; Nitric Oxide Synthase; Oligopeptides; Organ Size; Quinolines; Rabbits; Receptors, Angiotensin; Vascular Resistance; Vasodilation | 1993 |
Tissue- and subtype-specific modulation of angiotensin II receptors by chronic treatment with cyclosporin A, angiotensin-converting enzyme inhibitors and AT1 antagonists.
Topics: Administration, Oral; Adrenal Cortex; Adrenal Medulla; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Cyclosporine; Down-Regulation; Drug Interactions; Imidazoles; Kidney; Lisinopril; Liver; Losartan; Male; Pyridines; Quinolines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles; Up-Regulation | 1995 |
Vasomotor responses in cyclosporin A-treated rats after chronic angiotensin blockade.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Cyclosporine; Heart; Heart Rate; Kidney; Lisinopril; Liver; Male; Organ Size; Quinolines; Rats; Rats, Wistar; Time Factors; Vasoconstriction; Vasodilation; Vasomotor System; Weight Gain | 1994 |
Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptozotocin-diabetic rats and nerve function.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Male; Motor Neurons; Neural Conduction; Neurons, Afferent; Peripheral Nerves; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Reference Values; Regional Blood Flow; Sciatic Nerve | 1993 |